RC
SYNH

RegentAtlantic Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

RegentAtlantic Capital’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,143
Closed -$1.35M – 450
2019
Q1 		$1.35M Buy
26,143
+534
+2% +$25.9K 0.09% 196
2018
Q4 		$1.01M Buy
+25,609
New +$1.19M 0.09% 211

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RegentAtlantic Capital's SYNH Position: Q2 2019 in Review

RegentAtlantic Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2019, closing a stake of 26,143 shares — an estimated $1.35M sold.

RegentAtlantic Capital first reported a position in SYNH in Q4 2018 and held it in 2 quarters. The position peaked at $1.35M in Q1 2019. 246 funds tracked by Wall St. Rank hold SYNH as of Q2 2019.

  • RegentAtlantic Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2019 after selling out during the quarter.
  • RegentAtlantic Capital sold 26,143 Syneos Health, Inc. Class A Common Stock shares in Q2 2019, an estimated $1.35M.
  • RegentAtlantic Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 2 quarters.
  • RegentAtlantic Capital's Syneos Health, Inc. Class A Common Stock position peaked at $1.35M in Q1 2019.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2019.

Based on RegentAtlantic Capital's 13F filing for Q2 2019, filed 23 Jul 2019.